ecrin-mdr-crcClinical2022Colorectal cancerColorectal CancerObservationalhttps://newmdr.ecrin.org/Study/79701China5ECRIN MDRNot yet recruitingfalseA two-arm, multicenter exploratory clinical study of anrotinib combined with piemprizumab and crapy in first-line treatment hemotheof metastatic colorectal cancerInterventions: Group A:Sequential therapy with arotinib, oxaliplatin, capecitabine, and paclitaxel;Group B:Simultaneous treatment with arotinib + oxaliplatin + capecitabine + paiampilizumab Primary outcome(s): ORR Study Design: Non randomized control2022-05-1579701ChiCTR2200060634